Study of ALTO-100 for bipolar depression
Part of Mental health clinical trials.
This study tests an investigational drug called ALTO-100 for people with bipolar disorder who are currently experiencing depression. It aims to see if ALTO-100 can help improve depressive symptoms when added to your current mood stabilizer or antipsychotic medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with bipolar I or bipolar II disorder and are currently having a depressive episode.
- You are currently taking a mood stabilizer (like lithium, lamotrigine, or valproic acid) or an approved antipsychotic medication (like olanzapine, quetiapine, or lurasidone) for at least 6 weeks, with no dose changes in the last 2 weeks.
- You are willing to follow all study procedures and attend all study visits.
- You are not pregnant or breastfeeding, and agree to use contraception if applicable.
- You do not have unstable medical conditions, a substance use disorder, or a history of allergic reaction to ALTO-100.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication called ALTO-207 can help people with depression that hasn't improved with standard antidepressants. You may qualify if you've tried multiple antidepressants without enough relief and are willing to add this experimental treatment to your current medication.
This trial tests a new medication called ABX-002 as an add-on to your current antidepressant. It's for people with moderate to severe depression who haven't gotten enough help from their current antidepressant alone.
This study tests a new oral medication (NBI-1065845) added to your current antidepressant to see if it's safe and tolerable over a long period for people with depression that hasn't fully responded to treatment.
This trial tests ALTO-300 as an add-on treatment for people with moderate to severe major depressive disorder (MDD). It aims to see whether ALTO-300 helps improve depression symptoms when you’re already on a stable antidepressant.
This study tests an experimental medication called ALTO-101 for people with schizophrenia who also have cognitive impairment (memory or thinking problems). It aims to see if the drug can improve these symptoms while you continue your current antipsychotic treatment.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
Hear when a new Bipolar Disorder I or II With a Major Depressive Episode trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.